Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05086796 · ClinicalTrials.gov registry record · NA
Substance Use Treatment and Recovery Team
A NA study, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 325
- Enrollment target
NCT05086796 is a NA study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 325 participants.
The verdict
NCT05086796, a NA study, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 325 participants
- Enrollment target
Study Summary
This study is a multi-site, randomized pragmatic trial being conducted at three diverse sites. The study, called the Substance Use Treatment and Recovery Team (START), will evaluate whether a collaborative care team increases the use of two interventions-medication for opioid use disorder (MOUD), and opioid use disorder (OUD) focused discharge planning-among hospitalized patients with OUD, and improves linkage to follow-up care relative to usual care. The START consists of an addiction medicine specialist and a care manager who will use evidence-based tools to decrease barriers to MOUD and engage patients with post-discharge OUD care. A total of 414 patients will be randomized from Cedars-Sinai Medical Center in Los Angeles, the University of New Mexico Hospital in Albuquerque, and Baystate Health in Springfield, Massachusetts to receive either START or usual care, stratifying by prior MOUD exposure and site.
Interventions
- BEHAVIORAL Substance Use Treatment and Recovery Team (START)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 325 participants |
| Start Date | 2021-11-11 |
| Est. Completion | 2023-12-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05086796
The ClinicalTrials.gov registry entry for NCT05086796 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Substance Use Treatment and Recovery Team (START) is the first listed.
NCT05086796 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05086796 about?
NCT05086796 is a clinical study titled "Substance Use Treatment and Recovery Team". This study is a multi-site, randomized pragmatic trial being conducted at three diverse sites. The study, called the Substance Use Treatment and Recovery Team (START), will evaluate whether a collaborative care team increases the use of two interventions-medication for opioid use disorder (MOUD), an...
What is the current status of trial NCT05086796?
This trial is currently completed. It is a NA study. The enrollment target is 325 participants. The study started on 2021-11-11. Estimated completion is 2023-12-19.
What interventions are being tested in trial NCT05086796?
The interventions under investigation include: Substance Use Treatment and Recovery Team (START) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05086796?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.